170 related articles for article (PubMed ID: 36675665)
21. [Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension].
Li S; Feng H; Zhu J; Zhong C; Leng X; Du R
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):287-90. PubMed ID: 12828169
[TBL] [Abstract][Full Text] [Related]
22. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome.
Zhou CZ; Wang RF; Lv WF; Fu YQ; Cheng DL; Zhu YJ; Hou CL; Ye XJ
World J Gastroenterol; 2020 Jun; 26(24):3472-3483. PubMed ID: 32655270
[TBL] [Abstract][Full Text] [Related]
23. Hepatic sinusoidal obstruction syndrome caused by the ingestion of
Cen P; Ding J; Jin J
J Int Med Res; 2021 Apr; 49(4):300060520980649. PubMed ID: 33845617
[TBL] [Abstract][Full Text] [Related]
24. Impact of propofol sedation on the diagnostic accuracy of hepatic venous pressure gradient measurements in patients with cirrhosis.
Ebrahimi F; Semela D; Heim M
Hepatol Int; 2022 Aug; 16(4):817-823. PubMed ID: 34699037
[TBL] [Abstract][Full Text] [Related]
25. Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
Huang Q; Zhang Q; Xu H; Zu M; Xiao J; Shen B
Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):445-452. PubMed ID: 36719828
[TBL] [Abstract][Full Text] [Related]
26. Wedged hepatic venous pressure does not reflect portal pressure in patients with cirrhosis and hepatic veno-venous communications.
Osada Y; Kanazawa H; Narahara Y; Mamiya Y; Nakatsuka K; Sakamoto C
Dig Dis Sci; 2008 Jan; 53(1):7-13. PubMed ID: 18058232
[TBL] [Abstract][Full Text] [Related]
27. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension.
Bissonnette J; Généreux A; Côté J; Nguyen B; Perreault P; Bouchard L; Pomier-Layrargues G
J Gastroenterol Hepatol; 2012 Aug; 27(8):1336-40. PubMed ID: 22554152
[TBL] [Abstract][Full Text] [Related]
28. Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: A multicenter retrospective study.
Wang C; Wang Y; Zhao J; Yang C; Zhu X; Niu H; Sun J; Xiong B
Heliyon; 2024 Jan; 10(1):e23455. PubMed ID: 38163189
[TBL] [Abstract][Full Text] [Related]
29. Partial splenic embolization is superior to intravenous somatostatin for decreasing portal pressure in cirrhotic patients: a dynamic self-controlled cohort study.
Liu J; Sun X; Ganguli S; Wehrenberg-Klee EP; Bhan I; Zhao Y; Zhao L; Meng K; Sun R; Yu H; Sun G
Scand J Gastroenterol; 2020 Nov; 55(11):1341-1346. PubMed ID: 33076704
[TBL] [Abstract][Full Text] [Related]
30. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique.
Silva-Junior G; Baiges A; Turon F; Torres F; Hernández-Gea V; Bosch J; García-Pagán JC
Hepatology; 2015 Nov; 62(5):1584-92. PubMed ID: 26238376
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients.
Thalheimer U; Leandro G; Samonakis DN; Triantos CK; Patch D; Burroughs AK
Dig Liver Dis; 2005 Aug; 37(8):601-8. PubMed ID: 15908290
[TBL] [Abstract][Full Text] [Related]
33. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis.
Lin HC; Tsai YT; Lee FY; Chang TT; Wang SS; Lay CS; Lee SD; Lo KJ
J Hepatol; 1989 Nov; 9(3):326-30. PubMed ID: 2607121
[TBL] [Abstract][Full Text] [Related]
34. A computational model of the hepatic circulation applied to analyze the sensitivity of hepatic venous pressure gradient (HVPG) in liver cirrhosis.
Wang T; Liang F; Zhou Z; Shi L
J Biomech; 2017 Dec; 65():23-31. PubMed ID: 29042056
[TBL] [Abstract][Full Text] [Related]
35. Computed tomography perfusion in liver and spleen for hepatitis B virus-related portal hypertension: A correlation study with hepatic venous pressure gradient.
Wang L; Zhang Y; Wu YF; Yue ZD; Fan ZH; Zhang CY; Liu FQ; Dong J
World J Gastroenterol; 2022 Nov; 28(42):6068-6077. PubMed ID: 36405387
[TBL] [Abstract][Full Text] [Related]
36. Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions.
Gressens SB; Cazals-Hatem D; Lloyd V; Plessier A; Payancé A; Lebrec D; Durand F; Socie G; Valla D; Paradis V; Michonneau D; Rautou PE
JHEP Rep; 2022 Nov; 4(11):100558. PubMed ID: 36160755
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the efficacy of TIPS in 27 patients with hepatic sinus obstruction syndrome in the near and medium term].
Wang L; Zhang Y; Wang XQ; Yue ZD; Fan ZH; Wu YF; Liu FQ; Dong J; Zhang K; Jiang L; Ding HG; Zhang YN
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):842-846. PubMed ID: 37723066
[No Abstract] [Full Text] [Related]
38. Intrahepatic veno-venous collateralization and misrepresentative hepatic venous pressure gradients in children.
Monroe EJ; Michalsky WS; Koo KSH; Shivaram GM; Hage AN; Hsu EK; Horslen SP; Chick JFB
Pediatr Radiol; 2020 Oct; 50(11):1579-1586. PubMed ID: 32583092
[TBL] [Abstract][Full Text] [Related]
39. Steatosis and portal hypertension.
Puoti C; Bellis L
Eur Rev Med Pharmacol Sci; 2005; 9(5):285-90. PubMed ID: 16231591
[TBL] [Abstract][Full Text] [Related]
40. Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.
Zhang W; Liu L; Zhang M; Zhang F; Peng C; Zhang B; Chen J; Li L; He J; Xiao J; Feng Y; Wang X; Xiong A; Yang L; Zou X; Yu Y; Zhuge Y
J Clin Transl Hepatol; 2021 Jun; 9(3):345-352. PubMed ID: 34221920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
